Insulin lispro
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/969624/Cv/2'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='96/969624/Cv/2'> | ||
| - | Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_lispro]. | + | Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_lispro]. Insulin lispro is a manufactured form of human insulin where the amino acids lysine and proline have been switched at the end of the B chain of the insulin molecule. This switch of amino acids mimics [[Insulin-like growth factor 1]] which also has lysine and proline in that order. |
<scene name='96/969624/Cv/3'>Insulin Lispro Analog</scene> ([[6nwv]]). | <scene name='96/969624/Cv/3'>Insulin Lispro Analog</scene> ([[6nwv]]). | ||
Revision as of 12:50, 8 June 2023
| |||||||||||
